SHI Fang-yu, LOU Li-li, XIE Wen, et al. Network Meta-analysis of Chinese Medicine Injections Combined with Transcatheter Arterial Chemoembolization for Liver Cancer[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(10): 180-187.
SHI Fang-yu, LOU Li-li, XIE Wen, et al. Network Meta-analysis of Chinese Medicine Injections Combined with Transcatheter Arterial Chemoembolization for Liver Cancer[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(10): 180-187. DOI: 10.13422/j.cnki.syfjx.201608100180.
Objective: To assess the clinical effects and safety of Chinese medicine injection combined with transcatheter arterial chemoembolization (TACE) for liver cancer by using network Meta-analysis. Method: The randomized controlled trials (RCTs) of Chinese medicine injections (CMIs) combined with TACE VS TACE alone for liver cancer were searched from PubMed
The Cochrane Library
EMBASE
CBM
Chinese Knowledge Infrastructure (CNKI)
Wanfang
and Chinese Scientific Journals Fulltext Database (VIP-CSJFD)
up to March 2015 since database establishment. The RCTs were screened and selected according to the predefined inclusion and exclusion criteria Data extraction and quality evaluation were done for the included RCTs by 2 independent researchers
and Bayesian network meta-analysis was done by using WinBugs 1.4 software. Result: The 91 RCTs including 6 493 patients were finally included. The results of network Meta-analysis showed that 7 kinds of CMIs combined with TACE were superior to TACE alone in the treatment of liver cancer in increasing effective rate and life quality
reducing nausea and vomiting
abnormal liver function and leukopenia incidence. In terms of efficacy for liver cancer
Kang'ai injection+TACE
Fufang Kushen injection+TACE
Aidi injection+TACE
Kanglaite injection+TACE
cinobufagin injection+TACE
and bruceolic oil emulsion injection+TACE were superior to astragalus polysaccharide injection+TACE
whereas there was no statistically significant difference with other injections+TACE. In terms of improving life quality
Fufang Kushen injection+TACE was prior to Aidi injection+TACE. There was no statistically significant difference among the 7 CHIs in reducing the incidence of nausea
vomiting and leukopenia. Conclusion: Based on the results of network Meta-analysis
7 CHIs combined with TACE have better efficacy and safety than TACE alone for liver cancer. Based on the probability ranking results
Kang'ai injection+TACE is more effective as compared with other 6 CHIs+TACE for increasing effective rate
and cinobufagin injection+TACE is more effective as compared with other 6 CHIs+TACE for improving the quality of life.